Home > Boards > US Listed > Biotechs >

Seattle Genetics (SGEN)

Add SGEN Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/4/2022 8:48:33 PM - Followers: 24 - Board type: Free - Posts Today: 0




Seattle Genetics, Inc. operates as a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer, including lymphoma, multiple myeloma, leukemia, and solid tumors. The company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize SGN-40, a humanized monoclonal antibody that is in phase I and phase II clinical development for patients with diffuse large B-cell lymphoma and multiple myeloma. It also has three other proprietary programs in ongoing clinical trials: SGN-33, SGN-35, and SGN-30. The company's SGN-33 is in a phase IIb clinical trial for the patients with acute myeloid leukemia or myelodysplastic syndromes; and SGN-30 and SGN-35 are in phase II clinical trails for the treatment of CD30-positive hematologic malignancies, such as Hodgkin's disease and anaplastic large cell lymphoma. In addition, it developed proprietary antibody-drug conjugate (ADC) technology comprising highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. The company's product candidates also include SGN-70, a humanized anti-CD70 monoclonal antibody with potent effector function and intrinsic cell-killing ability; and SGN-75, which consists of an anti-CD70 monoclonal antibody linked to an auristatin derivative using its proprietary ADC technology. Seattle Genetics has license agreements with Bayer, CuraGen, Progenics, MedImmune, and PDL BioPharma to use its proprietary ADC technology with their monoclonal antibodies; and an ADC co-development agreement with Agensys and Celera Genomics. The company was founded in 1997 and is headquartered in Bothell, Washington

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGEN News: Analysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Seagen (SGEN) 05/24/2022 06:35:24 PM
SGEN News: Analysts’ Top Healthcare Picks: Medtronic (MDT), Seagen (SGEN) 05/23/2022 08:25:34 PM
SGEN News: Current Report Filing (8-k) 05/23/2022 04:11:49 AM
SGEN News: Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combination With Trastuzumab in HER2-Positive Metastatic Colorectal Cancer 05/23/2022 04:00:00 AM
SGEN News: Current Report Filing (8-k) 05/19/2022 12:49:37 PM
News News Alert: Analysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Seagen (SGEN) 05/24/2022 06:35:24 PM
#274   Astellas Pharma, Seagen Get CHMP Positive Opinion for Padcev Phosphene 01/04/22 08:48:33 PM
#273   Seagen and Astellas’ Padcev for Urothelial Cancer Phosphene 08/18/21 08:05:01 PM
#272   Seagen, RemeGen Ink $2.6B License Agreement for Anti-HER2 Phosphene 08/18/21 08:03:28 PM
#271   EMA Committee Recommends Approval for Seagen's Tukysa in Phosphene 12/13/20 07:52:28 AM
#270   BREAKING NEWS: $SGEN 3 Top Growth Stocks to whytestocks 11/14/20 12:30:18 PM
#269   Seattle Genetics (SGEN) to Release Earnings on 10/29/20 Phosphene 10/22/20 10:38:27 AM
#268   As a longtime SGEN shareholder, this price rise vinmantoo 10/13/20 01:58:19 PM
#267   Seattle Genetics shortens name to Seagen, dropping local Phosphene 10/13/20 09:52:32 AM
#266   Merck & Co to buy $1bn stake in Phosphene 10/07/20 12:00:46 PM
#265   Seattle Genetics plans manufacturing expansion with cash from Phosphene 09/28/20 12:05:41 PM
#264   Seattle Genetics and Genmab Present Data from Tisotumab Phosphene 09/21/20 02:22:47 PM
#263   Astellas, Seattle Genetics' Padcev bladder cancer trial stops Phosphene 09/18/20 11:58:17 AM
#262   Breaking News: $SGEN Merck Inks Multibillion-Dollar Deal With whytestocks 09/14/20 10:16:22 PM
#261   NEWS: $SGEN Seattle Genetics and Merck Announce Two whytestocks 09/14/20 10:00:28 PM
#260   The Baker Brothers have 27% ownership. Phosphene 08/30/20 11:08:49 PM
#259   Seattle Genetics to Receive Milestone Payment Under ADC Phosphene 08/30/20 10:18:18 PM
#258   Seattle Genetics Appoints Ted W. Love, M.D., to Phosphene 08/22/20 12:48:34 PM
#257   Hmmm maybe US deny for now T695 08/19/20 03:57:41 PM
#256   Seattle Genetics gets FDA approval for breast cancer Phosphene 04/17/20 08:35:25 PM
#255   How a Seattle Genetics cancer drug could help Phosphene 04/13/20 07:52:47 AM
#254   https://mobile.twitter.com/SeattleGenetics/status/1220436036997660672 mellow fellow 01/23/20 05:13:55 PM
#253   Seattle Genetics Achieves Milestone Following European Commission Approval mellow fellow 01/21/20 05:33:47 PM
#252   $SGEN bears are running https://news.squeezereport.com/short-squeeze whytestocks 11/12/19 11:25:23 AM
#251   Seattle Genetics will receive an upfront payment and Phosphene 11/06/19 12:16:41 PM
#250   News: $SGEN Seattle Genetics Announces Positive Topline Results whytestocks 10/21/19 12:45:26 PM
#249   News: $SGEN Here's Why Seattle Genetics Stock Jumped whytestocks 09/30/19 02:00:22 PM
#248   News: $SGEN Initial Results from MOUNTAINEER Trial Show whytestocks 09/29/19 09:10:29 AM
#247   News: $SGEN Seattle Genetics and Astellas Announce Results whytestocks 09/28/19 08:00:21 AM
#246   SGEN DAY PennyStock Alert 09/16/19 09:06:04 AM
#245   “The current standard of care for initial treatment crudeoil24 11/16/18 03:00:53 PM
#244   SGEN is a great $$$$$ opportunity. crudeoil24 11/16/18 02:52:58 PM
#243   Also, Seattle pounded the Packers last night! crudeoil24 11/16/18 02:52:19 PM
#242   Agree! crudeoil24 11/16/18 02:51:36 PM
#241   https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626079.htm crudeoil24 11/16/18 02:50:15 PM
#240   Boom! > FDA approves Adcetris > SGEN crudeoil24 11/16/18 02:31:48 PM
#239   SGEN is looking to bust $70. I think 46er 06/12/18 03:20:32 PM
#238   $SGEN OVER BOUGHT. RETRACE TO $20 imo coming BottomBounce 11/29/17 12:44:51 AM
#237   There's a whole little flock of new collaborations shub 10/11/17 02:25:41 PM
#236   It sure is an incoherent and dispersed bunch shub 10/03/17 03:39:49 PM
#235   Thanks for the tips. I'll sure take a cdaniel394 10/03/17 03:20:48 PM
#234   CD: Took a nibble of AMFE but it shub 10/03/17 03:17:41 PM
#233   Thanks C Daniel: shub 10/03/17 02:44:03 PM
#232   Thank you. Just had a friends brother who cdaniel394 10/03/17 02:42:51 PM
#231   With all their drugs in testing or trials, shub 10/03/17 02:41:34 PM
#230   Also, I don't know your risk tolerance, but cdaniel394 10/03/17 02:38:19 PM
#229   Quite all right. Been in SGEN since the cdaniel394 10/03/17 02:35:40 PM
#228   Sorry, wasn't paying attention to the time line, shub 10/02/17 03:31:25 PM
#227   Easy to make that call when hindsight is 20/20. cdaniel394 10/02/17 03:27:25 PM
#226   nope, shub 10/02/17 03:23:39 PM
#225   This up big on take over speculation? cdaniel394 08/31/17 01:23:12 PM
Consent Preferences